Inhibition of Akt signaling associated pathways can be a target for reducing age-related macular degeneration [56] Alzheimer’s disease [57], and Parkinson’s disease [58]. The gene discussed is AKT1; the disease is early-onset autosomal dominant Alzheimer disease.